Bioactive compounds featuring natural product-inspired three-dimensional molecular architectures exhibit higher rate of clinical success compared to synthetically less challenging flat aromatic drug candidates. Accessing such complex multi-chiral scaffolds is a daring task and is often precluded by the limitations of organic chemistry or avoided by medicinal chemist...